Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 22, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - April 22, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 29     Next >>     Go To Page:

4/21/18 - An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR.)
GW Pharmaceuticals plc's cannabis-based drug for epilepsy, Epidiolex, won the unanimous backing of an advisory panel to the FDA on April 19, 2018. The FDA's final decision on Epidiolex is expected by June 27, 2018. If approved, Epidiolex would be the first-ever medicine derived from a marijuana plant to be greenlighted by the FDA.
4/20/18 - Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws [Syrian Arab News Agency]
-Advanced Biomedical Technologies Inc., a developer and manufacturer of orthopaedic internal fixation devices, announced today that it has received approval from the China Food and Drug Administration for its polymer orthopaedic internal fixation screws. Company CEO Ms Hui Wang said, Today is a momentous day for our company and biomaterial technolo
4/20/18 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
4/20/18 - Nutra Pharma Partners with NxGen Brands for Nyloxin Distribution [Sudan Tribune]
-via OTC PR WIRE Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter pain management market, announced today that they have partnered with NxGen Brands, LLC; a company specializing in the sales and marketing of innovative healthcare products and service solutions, to market and distribute
4/20/18 - P&G to buy majority stake in Merck India business for Rs1,300 crore [Tehran Times (Iran)]
Procter& Gamble Co. will buy a majority stake in Merck Ltd, the Indian publicly traded unit of the German drug maker, for Rs1, 289.88 crore, as part of a global transaction to acquire Merck KGaAs international consumer health business for $4.2 billion. P&G will acquire a 51.8% stake in Merck Ltd, a move that will require the American consumer goods
4/20/18 - Sunovion Announces Health Canada Approval of Latuda (lurasidone HCl) to Treat Adolescents (13 to 17 years of age) with Bipolar Depression
Sunovion Pharmaceuticals Inc. today announced that Health Canada has approved the Supplemental New Drug Submission that expands the use of Latuda to include the acute management of depressive episodes associated with bipolar I disorder in adolescents. LATUDA is currently indicated in Canada for the management of the manifestations of...
4/20/18 - U.S. Sleep Market 2018: Competitive & Operating Analysis 1995-2017 & 2018-2023 Featuring ResMed, Respironics, SleepMed, Novasom, Tempur Sealy, Sleep Numbero & Simmons Serta
The "The U.S. Sleep Market 2018: Competitive& Operating Analysis" report has been added to ResearchAndMarkets.com' s offering. All of this has become a $28.6 billion a year industry. First launched in 1977, there are now an estimated 4,700 sleep labs or centers in the United States.
4/20/18 - U.S. Sleep Market 2018: Competitive & Operating Analysis 1995-2017, with 2018 and 2023 forecasts
The "The U.S. Sleep Market 2018: Competitive& Operating Analysis" report has been added to ResearchAndMarkets.com' s offering.. All of this has become a $28.6 billion a year industry. As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. First launched in 1977, there are
4/19/18 - Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws
Advanced Biomedical Technologies Inc., a developer and manufacturer of orthopaedic internal fixation devices, announced today that it has received approval from the China Food and Drug Administration for its polymer orthopaedic internal fixation screws. Company CEO Ms Hui Wang said, Today is a momentous day for our company and biomaterial tech
4/19/18 - HEALTH & SUPPORT
Monday evenings at 63 Jefferson Ave., Salem; and from noon to 1:30 p.m. Fridays at 75 Lindall St., Danvers. The Beverly and Addison Gilbert Hospital's Speakers Bureau is a free service designed to bring timely information on a variety of health-related topics. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors' conference room at
4/19/18 - Nutra Pharma Partners with NxGen Brands for Nyloxin Distribution
via OTC PR WIRE Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, announced today that they have partnered with NxGen Brands, LLC; a company specializing in the sales and marketing of innovative healthcare products and service solutions, to market and dist
4/19/18 - Teva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership
Teva Pharmaceutical Industries has announced that Teva and the Procter& Gamble Company have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market OTC medicines. PGT Healthcare has grown into a significant presence in over 50 countries, mainly in Europe and Asia, using market-leading brands such as V
4/18/18 - 'Imagine that entire crowd at a Wolfpack game deceased.' Jeff Sessions says opioid deaths would fill a stadium. [The News & Observer (Raleigh, N.C.)]
In Raleigh on Tuesday afternoon to meet with law enforcement and federal prosecutors in North Carolina, Sessions laid out some of the ideas the Trump administration has for battling a crisis with opioids that he said left 64,000 dead in this country in 2016.. Sessions, a former Republican senator from Alabama who rolled back many of the Justice Dep
4/18/18 - EDITORIAL: People shouldn't have to struggle with hearing loss [The Citizens' Voice, Wilkes-Barre, Pa.]
"Cost has for many years been the number one problem," Barbara Kelley, executive director and CEO of the Hearing Loss Association of America told Kaiser. Last year Congress passed a law allowing the Food and Drug Administration to authorize over-the-counter hearing aids for people with mild to moderate hearing loss. A a new bipartisan Senate bill,
4/18/18 - Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference
Eloxx Pharmaceuticals, Inc.,, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that two abstracts, including one Later Breaker, for its lead...
4/18/18 - Mitsubishi Tanabe Pharma America Announces ALS Presentations At American Academy Of Neurology Annual Meeting
"While it's been nearly one year since the FDA approved a second treatment option for ALS, there is still much to learn about this devastating disease," said Jean Hubble, M.D., Vice President of Medical Affairs, MTPA. Big Data Analytics for Early Diagnosis of Amyotrophic Lateral Sclerosis Abstract 459, Poster Session P4, Wednesday, April 25 from 11
4/17/18 - Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO ER in Preferred Formulary Position
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that two large Northeast regional health plans have placed ARYMO ER extended-release tablets for oral use only CII in a preferred formulary position..
4/17/18 - Global Point of Care Testing (POCT) Devices Market Trend, Segmentation, Opportunities and Forecast To 2024
PUNE, INDIA, April 17, 2018/ EINPresswire.com/ WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report Global Point of Care Testing Devices Outlook 2024. The global point of care testing diagnostics market is estimated to reach USD 20 billion by the year 2024.. Cholestech In
4/17/18 - Halo Pharma Simplifies Topical Drug Product Development and Manufacturing
Halo Pharma will be discussing its capabilities in topical drug products at CPhI NA, Booth 1549, at the Pennsylvania Convention Center, April 24-26. Topical drug products, which Research and Markets predicts will reach global sales of $194.2 billion by 2024, target localized skin sites or offer systemic penetration by formulations that are easily a
4/17/18 - Point-of-Care Testing (POCT) Market Research Growth by Regions, Type, Application, Forecast Analysis and Top Competitors Like F. Hoffmann-La Roche Ltd, Siemens AG & Ab: The global point-of-care testing market report contains an in-depth profiling of
Pune, India 04/17/2018 Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson& Johnson, Alere Inc., Instrumentation Laborato
4/16/18 - Acerus to Present at the Next CHINABIO Partnering Forum
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation announced that is has been selected to present at the annual CHINABIO Partnering Forum 2018 to be held in Suzhou, China, on April 25 and 26, 2018. Acerus has already partnered NATESTO , a testosterone nasal gel for testosterone replacement therapy
4/16/18 - AREA EVENTS
HAYS- The Ellis County Drug Enforcement Unit will operate two collection sites from 10 a.m. to 2 p.m. April 28 during the Drug Enforcement Agency's Take Back Prescription Drug Day. Uniformed officers will be at Good Samaritan Center, 2700 Canal, and Hays Convention and Visitors Bureau, 2700 Vine, both in Hays. Kansas Wesleyan University will host t
4/16/18 - Contract Pharmaceutical Manufacturing, Research and Packaging Market Analysis and Forecast 2017-2022
PUNE, INDIA, April 16, 2018/ EINPresswire.com/ WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging. The primary objective of this report is to provide in-depth knowledge of the global pharma
4/16/18 - First clinical study successfully completed with X842, an innovative promising treatment for severe erosive GERD
The Basel, Switzerland- based biotech company Cinclus Pharma AG today announced that it has successfully completed the first clinical Phase 1 study of its lead compound X842, for the treatment of severe erosive Gastroesophageal reflux disease. In the US and Europe, 20-40% of adult population suffer from reflux disease. The acid reflux market- worth
4/16/18 - Ohio Residents Urged to Get New Joint Pain 'Vaccine'
Imagine turning back the clock on your achy joints and muscles. An all natural supplement by Optimum Life Labs called Joint Nirvana is now available in Ohio and people are calling it "the" joint and muscle pain "vaccine" Big Pharma doesn't want you to know about. "I've tried every pain pill the doctor has ever prescribed me and Joint Nirvana is th
Articles(s): 1 - 25 of 29     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415